Multiresistant acinetobacter in the UK: How big a threat?

Juliana Coelho*, Neil Woodford, Jane Turton, David Livermore

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

74 Citations (Scopus)


In summary, multiresistant acinetobacter strains are spreading and carbapenem resistance is becoming more common. Whilst spread on the scale of MRSA seeMS improbable, it is clear that outbreaks can cause severe problems, either locally or across groups of hospitals. Sentinel surveillance is necessary to monitor and control the presence of the organism in the hospital environment. Scrupulous infection control measures, together with appropriate antibiotic use are critical for control. In the longer term, there is growing need for new therapeutic options.

Original languageEnglish
Pages (from-to)167-169
Number of pages3
JournalJournal of Hospital Infection
Issue number3
Publication statusPublished - Nov 2004

Bibliographical note

Funding Information:
J.C.'s work on Acinetobacter spp. is supported by AstraZeneca.


  • Gaussian source
  • Solar radiation
  • View factor


Dive into the research topics of 'Multiresistant acinetobacter in the UK: How big a threat?'. Together they form a unique fingerprint.

Cite this